首页|期刊导航|老年心脏病学杂志（英文版）|Real world effectiveness of PCSK-9 inhibitors combined with statins versus statins-based therapy among patients with very high risk of atherosclerotic cardiovascular disease in China (RWE-PCSK study)

Real world effectiveness of PCSK-9 inhibitors combined with statins versus statins-based therapy among patients with very high risk of atherosclerotic cardiovascular disease in China (RWE-PCSK study)

Yu-Qi LIU Yan-Qing GUO Xiao-Jian HONG Rong-Chong HUANG Feng-Shun JIA Jia-Yu LI Qing LI Jia-Mei LIU Xin-Ping LIU Yu-Guo LIU Hong-Gang NIE Dan-Dan LI Bing SHAO Xiao-Yu SHEN Hai-Qing SONG Yi-Jun SONG Li-Jun WANG Shuo WANG Dong-Mei WU Jing XIA Zhi-Yong YANG Hong-Ying YU Meng CHAI Hui ZHANG Tie-Mei ZHANG Ji-Yi ZHAO Liang-Chen ZHAO Ming-Qi ZHENG Yun-Dai CHEN Hong-Liang CONG Xiao-Qiang CONG Jun DAI Rong-Pin DU Ming GAO Jin-Cheng GUO

老年心脏病学杂志（英文版）2021，Vol.18Issue(4)：261-270,10.

Real world effectiveness of PCSK-9 inhibitors combined with statins versus statins-based therapy among patients with very high risk of atherosclerotic cardiovascular disease in China (RWE-PCSK study)

Yu-Qi LIU ¹Yan-Qing GUO ²Xiao-Jian HONG ³Rong-Chong HUANG ⁴Feng-Shun JIA ⁵Jia-Yu LI ⁶Qing LI ⁷Jia-Mei LIU ⁸Xin-Ping LIU ⁷Yu-Guo LIU ⁹Hong-Gang NIE ¹⁰Dan-Dan LI ¹Bing SHAO ¹¹Xiao-Yu SHEN ¹²Hai-Qing SONG ¹³Yi-Jun SONG ¹⁴Li-Jun WANG ¹⁵Shuo WANG ¹⁶Dong-Mei WU ¹⁷Jing XIA ¹⁸Zhi-Yong YANG ¹⁹Hong-Ying YU ²⁰Meng CHAI ²¹Hui ZHANG ²²Tie-Mei ZHANG ²³Ji-Yi ZHAO ²⁴Liang-Chen ZHAO ²⁵Ming-Qi ZHENG ²⁶Yun-Dai CHEN ¹Hong-Liang CONG ²⁷Xiao-Qiang CONG ²⁸Jun DAI ²⁹Rong-Pin DU ³⁰Ming GAO ³¹Jin-Cheng GUO³²

作者信息

1. Department of Cardiology, Chinese PLA General Hospital Beijing, China
2. Department of Cardiology, Shanxi Cardiovascular Hospital, Taiyuan, China
3. Department of Cardiology, the Fourth Affiliated Hospital of Harbin Medical University, Harbin, China
4. Department of Cardiology, Beijing Friendship Hospital, Capital Medical University, Beijing, China
5. Department of Cardiology, Tangshan Worker's Hospital, Tangshan, China
6. Department of Cardiology, China-Japan Friendship Hospital Affiliated Jilin University, Changchun, China
7. Department of Cardiology, Handan Central Hospital, Hebei, China
8. Heart Center, Beijing Key Laboratory of Hypertension, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China
9. Department of Cardiology, the First Affiliated Hospital of Dalian Medical University, Liaoning, China
10. Department of Cardiology, the Second Affiliated Hospital of Harbin Medical University, Harbin, China
11. Department of Cardiology, the Second Affiliated Hospital of Shenyang Medical College, Shenyang, China
12. Department of Cardiology, the Second Hospital of Shanxi Medical University, Taiyuan, China
13. Department of Neurology, Xuanwu Hospital Capital Medical University, Beijing, China
14. Department of Neurology, Tianjin Medical University General Hospital, Tianjin, China
15. Department of Cardiology, the Third Hospital of Shijiazhuang City, Shijiazhuang, China
16. Department of Cardiology, the First Hospital of Shijiazhuang City, Shijiazhuang, China
17. Department of Cardiology, Taigang General Hospital, Shanxi Medical University, Taiyuan, China
18. Department of Cardiology, the Sixth Medical Center of Chinese PLA General Hospital Beijing, China
19. Department of Cardiology, Shengjing Hospital of China Medical University, Shengyang, China
20. Department of Cardiology, Daqing Oilfield General Hospital, Heilongjiang, China
21. Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing Key Laboratory of Precision Medicine of Coronary Atherosclerotic Disease, Clinical Center for Coronary Heart Disease, Capital Medical University, Beijing, China
22. Department of Cardiology, the Second Hospital of Baoding, Hebei, China
23. Department of Cardiology and Macrovascular Disease, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
24. Department of Cardiology, the First Affiliated Hospital of Harbin Medical University, Harbin, China
25. Department of Cardiology, Jilin Central Hospital, Changchun, China
26. Heart Center, the First Hospital of Hebei Medical University, Shijiazhuang, China
27. Department of Cardiology, Tianjin Chest Hospital, Tianjin, China
28. Department of Cardiology, the First Hospital of Jilin University, Changchun, China
29. Department of Cardiology, Fuwai Hospital, National Center for Cardiovascular Disease, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
30. Department of Cardiology, Hebei People's Hospital, Shijiazhuang, China
31. Department of Cardiology, Kailuan General Hospital, Hebei Union University, Tangshan, China
32. Department of Cardiology, Beijing Luhe Hospital Capital Medical University, Beijing, China
折叠

摘要

引用本文复制引用

Yu-Qi LIU,Yan-Qing GUO,Xiao-Jian HONG,Rong-Chong HUANG,Feng-Shun JIA,Jia-Yu LI,Qing LI,Jia-Mei LIU,Xin-Ping LIU,Yu-Guo LIU,Hong-Gang NIE,Dan-Dan LI,Bing SHAO,Xiao-Yu SHEN,Hai-Qing SONG,Yi-Jun SONG,Li-Jun WANG,Shuo WANG,Dong-Mei WU,Jing XIA,Zhi-Yong YANG,Hong-Ying YU,Meng CHAI,Hui ZHANG,Tie-Mei ZHANG,Ji-Yi ZHAO,Liang-Chen ZHAO,Ming-Qi ZHENG,Yun-Dai CHEN,Hong-Liang CONG,Xiao-Qiang CONG,Jun DAI,Rong-Pin DU,Ming GAO,Jin-Cheng GUO..Real world effectiveness of PCSK-9 inhibitors combined with statins versus statins-based therapy among patients with very high risk of atherosclerotic cardiovascular disease in China (RWE-PCSK study)[J].老年心脏病学杂志（英文版）,2021,18(4):261-270,10.

基金项目

This study was supported by the China Cardiovascular Health Alliance-Advanced Fund (2019-CCA-ACCESS-054),and the Beijing Lisheng Cardiovascular Health Foundation Pilot Fund Key Projects.All authors had no conflicts of interest to disclose. （2019-CCA-ACCESS-054）

老年心脏病学杂志（英文版）

OACSCDSCI

ISSN：1671-5411

访问量0

下载量0

段落导航